Elanco Animal Health Incorporated Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Elanco Animal Health Incorporated Common Stock (ELAN) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.2%, relative volume 1.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
39 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ELAN is in a stage 3 topping pattern, week 6. Currently in a 84-day base; basing ADR 4.3% (broad 3.0%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 6.7% / 7.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
ELAN is held by 12 ETFs as of Mar 2026. Top owner: IJH at 0.37% weight, $394M notional. Top 3 carry $1.0B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJHiShares Core S&P Mid-Cap ETF | 0.37% | $394M |
| VTIVanguard Total Stock Market ETF | 0.02% | $379M |
| VBVanguard Small Cap ETF | 0.17% | $274M |
| VBRVanguard Small Cap Value ETF | 0.29% | $175M |
| VXFVanguard Extended Market ETF | 0.16% | $133M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | 0.37% | $90M |
| IWRiShares Russell Midcap ETF | 0.09% | $45M |
| IWDiShares Russell 1000 Value ETF | 0.04% | $27M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.02% | $15M |
| IUSGiShares Core S&P U.S. Growth ETF | 0.04% | $10M |
Showing 10 of 12 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELAN Jan avg: 4.26% median: 2.87% win: 50% σ: 6.40% n: 4 2022-04-12 → 2026-05-29 | ELAN Feb avg: -1.54% median: 0.33% win: 50% σ: 12.47% n: 4 2022-04-12 → 2026-05-29 | ELAN Mar avg: -7.74% median: -7.68% win: 25% σ: 8.48% n: 4 2022-04-12 → 2026-05-29 | ELAN Apr avg: -7.46% median: -6.52% win: 20% σ: 7.64% n: 5 2022-04-12 → 2026-05-29 | ELAN May avg: 12.49% median: 6.62% win: 60% σ: 24.62% n: 5 2022-04-12 → 2026-05-29 | ELAN Jun avg: -1.47% median: -5.46% win: 50% σ: 20.10% n: 4 2022-04-12 → 2026-05-29 (current) | ELAN Jul avg: 2.34% median: -0.50% win: 50% σ: 12.88% n: 4 2022-04-12 → 2026-05-29 | ELAN Aug avg: 7.13% median: 9.86% win: 75% σ: 25.50% n: 4 2022-04-12 → 2026-05-29 | ELAN Sep avg: -5.28% median: -6.46% win: 25% σ: 11.46% n: 4 2022-04-12 → 2026-05-29 | ELAN Oct avg: -4.83% median: -3.84% win: 50% σ: 15.36% n: 4 2022-04-12 → 2026-05-29 | ELAN Nov avg: 10.21% median: 4.78% win: 75% σ: 16.03% n: 4 2022-04-12 → 2026-05-29 | ELAN Dec avg: 2.59% median: -3.90% win: 25% σ: 16.09% n: 4 2022-04-12 → 2026-05-29 |